L. Kappos Et Al. , "Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)," 14th Congress of European-Federation-of-Neurological-Societies , vol.17, Geneva, Switzerland, pp.234, 2010
Kappos, L. Et Al. 2010. Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS). 14th Congress of European-Federation-of-Neurological-Societies , (Geneva, Switzerland), 234.
Kappos, L., Wiendl, H., Kaufman, M., Rose, J., Havrdova, E., Boyko, A., ... Eraksoy, M.(2010). Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS) . 14th Congress of European-Federation-of-Neurological-Societies (pp.234). Geneva, Switzerland
Kappos, L. Et Al. "Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)," 14th Congress of European-Federation-of-Neurological-Societies, Geneva, Switzerland, 2010
Kappos, L. Et Al. "Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)." 14th Congress of European-Federation-of-Neurological-Societies , Geneva, Switzerland, pp.234, 2010
Kappos, L. Et Al. (2010) . "Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)." 14th Congress of European-Federation-of-Neurological-Societies , Geneva, Switzerland, p.234.
@conferencepaper{conferencepaper, author={L. Kappos Et Al. }, title={Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)}, congress name={14th Congress of European-Federation-of-Neurological-Societies}, city={Geneva}, country={Switzerland}, year={2010}, pages={234} }